{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:37:35Z","timestamp":1789180655059,"version":"build-2803163510"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0113311","type":"journal-article","created":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T15:53:52Z","timestamp":1417449232000},"page":"e113311","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy and Safety of Fixed-Dose Artesunate-Amodiaquine vs. Artemether-Lumefantrine for Repeated Treatment of Uncomplicated Malaria in Ugandan Children"],"prefix":"10.1371","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct00699920","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Adoke","family":"Yeka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Lameyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kibuuka","family":"Afizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudangha","family":"Fredrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robinson","family":"Lukwago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses R.","family":"Kamya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrose O.","family":"Talisuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,12,1]]},"reference":[{"key":"ref1","unstructured":"WHO (2012) World malaria report 2012, World Health Organization, 2012. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/malaria\/publications\/world_malaria_report_2012\/en\/\" xlink:type=\"simple\">www.who.int\/malaria\/publications\/world_malaria_report_2012\/en\/<\/ext-link>."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11908-010-0099-y","article-title":"Drug-Resistant Malaria: The Era of ACT","volume":"12","author":"JT Lin","year":"2010","journal-title":"Curr Infect Dis Rep"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.1097\/MJT.0b013e318209e031","article-title":"A simple dose regimen of artesunate and amodiaquine based on age or body weight range for uncomplicated falciparum malaria in children: comparison of therapeutic efficacy with standard dose regimen of artesunate and amodiaquine and artemether-lumefantrine","volume":"19","author":"GO Gbotosho","year":"2012","journal-title":"Am J Ther"},{"key":"ref4","volume":"334","unstructured":"Griffin A (2007) New once a day, fixed dose antimalarial is now available for adults and children. BMJ <volume>334<\/volume>:: 443. 334\/7591\/443-a [pii]; 10.1136\/bmj.39139.346782.DB [doi]."},{"key":"ref5","unstructured":"WHO (2011) World Health organisation, WHO Model List of. Essential Medicines for Children. 3rd list. (March 2011); available at whqlibdoc.who.int\/hq\/2011\/a95054_eng.pdf, accessed January 2014."},{"key":"ref6","volume":"9","unstructured":"Ayede IA, Falade AG, Sowunmi A, Jansen FH (2010) An open randomized clinical trial in comparing two artesunate-based combination treatments on Plasmodium falciparum malaria in Nigerian children: artesunate\/sulphamethoxypyrazine\/pyrimethamine (fixed dose over 24 hours) versus artesunate\/amodiaquine (fixed dose over 48 hours). Malar J <volume>9<\/volume>:: 378. 1475-2875-9-378 [pii]; 10.1186\/1475-2875-9-378 [doi]."},{"key":"ref7","volume":"11","unstructured":"Espie E, Lima A, Atua B, Dhorda M, Flevaud L, <etal>et al<\/etal>.<bold>.<\/bold> (2012) Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial. Malar J <volume>11<\/volume>:: 174. 1475-2875-11-174 [pii]; 10.1186\/1475-2875-11-174 [doi]."},{"key":"ref8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/599378","article-title":"Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial","volume":"200","author":"JF Faucher","year":"2009","journal-title":"J Infect Dis"},{"key":"ref9","volume":"15","unstructured":"Faye B, Offianan AT, Ndiaye JL, Tine RC, Toure W, <etal>et al<\/etal>.<bold>.<\/bold> (2010) Efficacy and tolerability of artesunate-amodiaquine (Camoquin plus) versus artemether-lumefantrine (Coartem) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast. Trop Med Int Health <volume>15<\/volume>:: 608\u2013613. TMI2487 [pii]; 10.1111\/j.1365-3156.2010.02487.x [doi]."},{"key":"ref10","volume":"7","unstructured":"Ndiaye JL, Faye B, Diouf AM, Kuete T, Cisse M, <etal>et al<\/etal>.<bold>.<\/bold> (2008) Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria. Malar J <volume>7<\/volume>:: 16. 1475-2875-7-16 [pii]; 10.1186\/1475-2875-7-16 [doi]."},{"key":"ref11","volume":"8","unstructured":"Ndiaye JL, Randrianarivelojosia M, Sagara I, Brasseur P, Ndiaye I, <etal>et al<\/etal>.<bold>.<\/bold> (2009) Randomized, multicentre assessment of the efficacy and safety of ASAQ\u2013a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria. Malar J <volume>8<\/volume>:: 125. 1475-2875-8-125 [pii]; 10.1186\/1475-2875-8-125 [doi]."},{"key":"ref12","volume":"8","unstructured":"Sirima SB, Tiono AB, Gansane A, Diarra A, Ouedraogo A, <etal>et al<\/etal>.<bold>.<\/bold> (2009) The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum. Malar J <volume>8<\/volume>:: 48. 1475-2875-8-48 [pii]; 10.1186\/1475-2875-8-48 [doi]."},{"key":"ref13","volume":"13","unstructured":"Kilama M, Smith DL, Hutchinson R, Kigozi R, Yeka A, <etal>et al<\/etal>.<bold>.<\/bold> (2014) Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda. Malar J <volume>13<\/volume>:: 111. 1475-2875-13-111 [pii]; 10.1186\/1475-2875-13-111 [doi]."},{"key":"ref14","volume":"8","unstructured":"Staedke SG, Chandler CI, DiLiberto D, Maiteki-Sebuguzi C, Nankya F, <etal>et al<\/etal>.<bold>.<\/bold> (2013) The PRIME trial protocol: evaluating the impact of an intervention implemented in public health centres on management of malaria and health outcomes of children using a cluster-randomised design in Tororo, Uganda. Implement Sci <volume>8<\/volume>:: 114. 1748-5908-8-114 [pii]; 10.1186\/1748-5908-8-114 [doi]."},{"key":"ref15","volume":"75","unstructured":"Okello PE, Van BW, Byaruhanga AM, Correwyn A, Roelants P, <etal>et al<\/etal>.<bold>.<\/bold> (2006) Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Hyg <volume>75<\/volume>:: 219\u2013225. 75\/2\/219 [pii]."},{"key":"ref16","unstructured":"WHO (2008) Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. Geneva: World Health Organization."},{"key":"ref17","unstructured":"WHO (2009) Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. Geneva: World Health Organisation."},{"key":"ref18","volume":"87","unstructured":"Sagara I, Fofana B, Gaudart J, Sidibe B, Togo A, <etal>et al<\/etal>.<bold>.<\/bold> (2012) Repeated artemisinin-based combination therapies in a malaria hyperendemic area of Mali: efficacy, safety, and public health impact. Am J Trop Med Hyg <volume>87<\/volume>:: 50\u201356. 87\/1\/50 [pii]; 10.4269\/ajtmh.2012.11-0649 [doi]."},{"key":"ref19","volume":"10","unstructured":"Ndiaye JL, Faye B, Gueye A, Tine R, Ndiaye D, <etal>et al<\/etal>.<bold>.<\/bold> (2011) Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. Malar J <volume>10<\/volume>:: 237. 1475-2875-10-237 [pii]; 10.1186\/1475-2875-10-237 [doi]."},{"key":"ref20","volume":"7","unstructured":"Adjei GO, Kurtzhals JA, Rodrigues OP, Alifrangis M, Hoegberg LC, <etal>et al<\/etal>.<bold>.<\/bold> (2008) Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up. Malar J <volume>7<\/volume>:: 127. 1475-2875-7-127 [pii]; 10.1186\/1475-2875-7-127 [doi]."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1086\/647946","article-title":"Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children","volume":"49","author":"E Arinaitwe","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Wanzira H, Kakuru A, Arinaitwe E, Bigira V, Muhindo MK, <etal>et al<\/etal>.<bold>.<\/bold> (2014) Longitudinal Outcomes in a Cohort of Ugandan Children Randomized to Artemether-lumefantrine Versus Dihydroartemisinin-piperaquine for the Treatment of Malaria. Clin Infect Dis. cid\/ciu353 [pii]; 10.1093\/cid\/ciu353 [doi].","DOI":"10.1093\/cid\/ciu353"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1128\/AAC.01412-09","article-title":"In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda","volume":"54","author":"SL Nsobya","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","volume":"193","unstructured":"Francis D, Nsobya SL, Talisuna A, Yeka A, Kamya MR, <etal>et al<\/etal>.<bold>.<\/bold> (2006) Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. J Infect Dis <volume>193<\/volume>:: 978\u2013986. JID35563 [pii]; 10.1086\/500951 [doi]."},{"key":"ref25","volume":"9","unstructured":"Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, <etal>et al<\/etal>.<bold>.<\/bold> (2010) Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J <volume>9<\/volume>:: 136. 1475-2875-9-136 [pii]; 10.1186\/1475-2875-9-136 [doi]."},{"key":"ref26","volume":"7","unstructured":"Okell LC, Drakeley CJ, Ghani AC, Bousema T, Sutherland CJ (2008) Reduction of transmission from malaria patients by artemisinin combination therapies: a pooled analysis of six randomized trials. Malar J <volume>7<\/volume>:: 125. 1475-2875-7-125 [pii]; 10.1186\/1475-2875-7-125 [doi]."},{"key":"ref27","volume":"84","unstructured":"Taylor W, Terlouw DJ, Olliaro PL, White NJ, Brasseur P, <etal>et al<\/etal>.<bold>.<\/bold> (2006) Use of weight-for-age-data to optimize tablet strength and dosing regimens for a new fixed-dose artesunate-amodiaquine combination for treating falciparum malaria. Bull World Health Organ <volume>84<\/volume>:: 956\u2013964. S0042-96862006001200011 [pii]."},{"key":"ref28","volume":"12","unstructured":"Schramm B, Valeh P, Baudin E, Mazinda CS, Smith R, <etal>et al<\/etal>.<bold>.<\/bold> (2013) Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia. Malar J <volume>12<\/volume>:: 250. 1475-2875-12-250 [pii]; 10.1186\/1475-2875-12-250 [doi]."},{"key":"ref29","volume":"82","unstructured":"Schoepflin S, Lin E, Kiniboro B, DaRe JT, Mehlotra RK, <etal>et al<\/etal>.<bold>.<\/bold> (2010) Treatment with coartem (artemether-lumefantrine) in Papua New Guinea. Am J Trop Med Hyg <volume>82<\/volume>:: 529\u2013534. 82\/4\/529 [pii]; 10.4269\/ajtmh.2010.09-0334 [doi]."},{"key":"ref30","unstructured":"UBOS and Macro International Inc (2010) Uganda Bureau of Statistics (UBOS) and Macro International Inc. 2007. Uganda Malaria indicator Survey 2009. Calverton, Maryland, USA."},{"key":"ref31","unstructured":"UBOS and Macro International Inc (2007) Uganda Bureau of Statistics (UBOS) and macro International Inc. 2007. Uganda Demographic and Health Survey 2006. Calverton, Maryland, USA."},{"key":"ref32","volume":"11","unstructured":"Trape JF, Tall A, Diagne N, Ndiath O, Ly AB, <etal>et al<\/etal>.<bold>.<\/bold> (2011) Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect Dis <volume>11<\/volume>:: 925\u2013932. S1473-3099(11)70194-3 [pii]; 10.1016\/S1473-3099(11)70194-3 [doi]."},{"key":"ref33","volume":"206","unstructured":"Moiroux N, Gomez MB, Pennetier C, Elanga E, Djenontin A, <etal>et al<\/etal>.<bold>.<\/bold> (2012) Changes in Anopheles funestus biting behavior following universal coverage of long-lasting insecticidal nets in Benin. J Infect Dis <volume>206<\/volume>:: 1622\u20131629. jis565 [pii]; 10.1093\/infdis\/jis565 [doi]."},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Lengeler C (2004) Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev CD000363. 10.1002\/14651858.CD000363.pub2 [doi].","DOI":"10.1002\/14651858.CD000363.pub2"},{"key":"ref35","volume":"12","unstructured":"Greenwood B, Targett G, Chandramohan D, Logan J, Schellenberg D (2012) Are insecticide treated bednets failing? Lancet Infect Dis <volume>12<\/volume>:: 512. S1473-3099(12)70105-6 [pii]; 10.1016\/S1473-3099(12)70105-6 [doi]."},{"key":"ref36","volume":"12","unstructured":"Meyer CG, Ehrhardt S (2012) Are insecticide treated bednets failing? Lancet Infect Dis <volume>12<\/volume>:: 513\u2013514. S1473-3099(12)70106-8 [pii]; 10.1016\/S1473-3099(12)70106-8 [doi]."},{"key":"ref37","volume":"12","unstructured":"Thiam S, Shoo R, Carter J (2012) Are insecticide treated bednets failing? Lancet Infect Dis <volume>12<\/volume>:: 512\u2013513. S1473-3099(12)70107-X [pii]; 10.1016\/S1473-3099(12)70107-X [doi]."},{"key":"ref38","volume":"361","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, <etal>et al<\/etal>.<bold>.<\/bold> (2009) Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med <volume>361<\/volume>:: 455\u2013467. 361\/5\/455 [pii]; 10.1056\/NEJMoa0808859 [doi]."},{"key":"ref39","volume":"366","unstructured":"Duffy PE, Sibley CH (2005) Are we losing artemisinin combination therapy already? Lancet <volume>366<\/volume>:: 1908-1909. S0140-6736(05)67768-9 [pii]; 10.1016\/S0140-6736(05)67768-9 [doi]."},{"key":"ref40","volume":"7","unstructured":"Holmgren G, Hamrin J, Svard J, Martensson A, Gil JP, <etal>et al<\/etal>.<bold>.<\/bold> (2007) Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa. Infect Genet Evol <volume>7<\/volume>:: 562\u2013569. S1567-1348(07)00041-X [pii]; 10.1016\/j.meegid.2007.03.005 [doi]."}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0113311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T21:17:47Z","timestamp":1566076667000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0113311"}},"subtitle":[],"editor":[{"given":"David Joseph","family":"Diemert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,12,1]]},"references-count":40,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2014,12,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0113311","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,1]]}}}